547 related articles for article (PubMed ID: 11160252)
1. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
2. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation.
Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J
Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263
[TBL] [Abstract][Full Text] [Related]
3. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats.
Abe M; Shibata K; Akatsu H; Shimizu N; Sakata N; Katsuragi T; Okada H
J Immunol; 2001 Oct; 167(8):4651-60. PubMed ID: 11591795
[TBL] [Abstract][Full Text] [Related]
4. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
5. Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma.
Fregonese L; Swan FJ; van Schadewijk A; Dolhnikoff M; Santos MA; Daha MR; Stolk J; Tschernig T; Sterk PJ; Hiemstra PS; Rabe KF; Mauad T
J Allergy Clin Immunol; 2005 Jun; 115(6):1148-54. PubMed ID: 15940127
[TBL] [Abstract][Full Text] [Related]
6. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy.
Drouin SM; Corry DB; Hollman TJ; Kildsgaard J; Wetsel RA
J Immunol; 2002 Nov; 169(10):5926-33. PubMed ID: 12421977
[TBL] [Abstract][Full Text] [Related]
7. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
[TBL] [Abstract][Full Text] [Related]
8. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells.
Wetsel RA
Immunol Lett; 1995 Jan; 44(2-3):183-7. PubMed ID: 7797249
[TBL] [Abstract][Full Text] [Related]
9. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
[TBL] [Abstract][Full Text] [Related]
11. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.
Haviland DL; McCoy RL; Whitehead WT; Akama H; Molmenti EP; Brown A; Haviland JC; Parks WC; Perlmutter DH; Wetsel RA
J Immunol; 1995 Feb; 154(4):1861-9. PubMed ID: 7836770
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of C5a receptor in mouse microvascular endothelial cells.
Laudes IJ; Chu JC; Huber-Lang M; Guo RF; Riedemann NC; Sarma JV; Mahdi F; Murphy HS; Speyer C; Lu KT; Lambris JD; Zetoune FS; Ward PA
J Immunol; 2002 Nov; 169(10):5962-70. PubMed ID: 12421982
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
Fukuoka Y; Ember JA; Hugli TE
Biochem Biophys Res Commun; 1998 Jan; 242(3):663-8. PubMed ID: 9464274
[TBL] [Abstract][Full Text] [Related]
16. A role for the C3a anaphylatoxin receptor in the effector phase of asthma.
Humbles AA; Lu B; Nilsson CA; Lilly C; Israel E; Fujiwara Y; Gerard NP; Gerard C
Nature; 2000 Aug; 406(6799):998-1001. PubMed ID: 10984054
[TBL] [Abstract][Full Text] [Related]
17. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
18. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin.
Kirchhoff K; Weinmann O; Zwirner J; Begemann G; Götze O; Kapp A; Werfel T
Immunology; 2001 Jun; 103(2):210-7. PubMed ID: 11412308
[TBL] [Abstract][Full Text] [Related]
19. The Complement C3a
Ren W; Liu Y; Wang X; Piao C; Ma Y; Qiu S; Jia L; Chen B; Wang Y; Jiang W; Zheng S; Liu C; Dai N; Lan F; Zhang H; Song WC; Du J
J Immunol; 2018 Mar; 200(5):1829-1838. PubMed ID: 29367209
[TBL] [Abstract][Full Text] [Related]
20. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
